$511 Million is the total value of VR Adviser, LLC's 22 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATHA | New | ATHIRA PHARMA INC | $28,089,000 | – | 1,521,623 | +100.0% | 5.50% | – |
| HGEN | New | HUMANIGEN INC | $24,818,000 | – | 2,332,516 | +100.0% | 4.86% | – |
| CRDF | New | CARDIFF ONCOLOGY INC | $18,049,000 | – | 1,271,985 | +100.0% | 3.53% | – |
| IMV | New | IMV INC | $17,760,000 | – | 4,000,000 | +100.0% | 3.47% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC | $11,864,000 | – | 800,000 | +100.0% | 2.32% | – |
| MTCR | New | METACRINE INC | $11,677,000 | – | 1,143,673 | +100.0% | 2.28% | – |
| ALXO | New | ALX ONCOLOGY HOLDINGS INC | $11,322,000 | – | 300,000 | +100.0% | 2.22% | – |
| UMRX | New | UNUM THERAPEUTICS INC | $10,191,000 | – | 4,355,273 | +100.0% | 1.99% | – |
| FSDC | New | FS DEVELOPMENT CORP-A | $5,599,000 | – | 500,000 | +100.0% | 1.10% | – |
| BCTG | New | BCTG ACQUISITION CORP | $5,180,000 | – | 500,000 | +100.0% | 1.01% | – |
| TSHA | New | TAYSHA GENE THERAPIES INC | $2,598,000 | – | 107,982 | +100.0% | 0.51% | – |
| GRTX | New | GALERA THERAPEUTICS INC | $467,000 | – | 51,653 | +100.0% | 0.09% | – |
| MDNA | New | MEDICENNA THERAPEUTICS CORP | $383,000 | – | 92,453 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.